Share
17,123 Posts.
lightbulb Created with Sketch. 2422
clock Created with Sketch. 17/04/17
14:38
Share
Originally posted by Fire Bull
↑
Not sure if this has already been posted but BTG released a trading update on 6 April. In particular, the following extract is potentially of interest to SRX s/holders:A strong performance from TheraSphere® and the addition of Galil Medical have helped cement our leadership in Interventional Oncology. EKOS has continued to increase market penetration, and we have achieved important milestones in our earlier stage businesses. There is good momentum across our business and we start the new financial year with confidence."
Expand
You still invested with us FB?
Last edited by
whytee :
17/04/17
Big week coming up. I reckon if 10% of the trial patients (around 40) have had resection or transplant, we're in with a shout...
